SIGYN THERAPEUTICS, INC. Net Change in Cash
SIGYN THERAPEUTICS, INC. (SIGY) reported Net Change in Cash of $73.43 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2025-11-14
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was $751.00, a 96.45% decline year-over-year.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was $21.15K, a 93.26% decline year-over-year.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $313.97K.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$259.57K.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $454.00, a 86.38% decline from fiscal 2023.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $3.33K.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$332.60K, a 229.64% decline from fiscal 2021.
- SIGYN THERAPEUTICS, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $256.55K, a 203.97% increase from fiscal 2020.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $73.43K 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | -$11.69K 10-Q · filed 2025-09-05 | ||||
| 2025-03-31 | $751.00 10-Q · filed 2025-05-20 | ||||
| 2024-12-31 | $454.00 10-K · filed 2025-04-15 | ||||
| 2024-09-30 | $153.10K 10-Q · filed 2025-11-14 | ||||
| 2024-06-30 | $41.95K 10-Q · filed 2025-09-05 | ||||
| 2024-03-31 | $21.15K 10-Q · filed 2025-05-20 | ||||
| 2023-12-31 | $3.33K 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $56.23K 10-Q · filed 2024-11-19 | ||||
| 2023-06-30 | $15.28K 10-Q · filed 2024-08-19 | ||||
| 2023-03-31 | $313.97K 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | -$332.60K 10-K · filed 2024-02-20 | ||||
| 2022-09-30 | -$312.83K 10-Q · filed 2023-11-14 | ||||
| 2022-06-30 | -$333.67K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | -$259.57K 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | $256.55K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $418.57K 10-Q · filed 2022-11-14 | ||||
| 2021-06-30 | $975.60K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | -$77.30K 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $84.40K 10-K · filed 2022-03-21 | ||||
| 2020-09-30 | $365.14K 10-Q · filed 2021-11-12 | -$500.00 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $101.62K 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | $136.46K 10-Q · filed 2021-05-17 | ||||
| 2019-09-30 | -$7.00K 10-Q · filed 2020-11-09 |